Yaron Ilan

Yaron Ilan's AcademicInfluence.com Rankings

Yaron Ilan

Physics

#6921

World Rank

#8912

Historical Rank

physics Degrees

Download Badge

Physics

Yaron Ilan's Degrees

Bachelors Physics Tel Aviv University
Masters Physics Tel Aviv University
PhD Physics Stanford University

Why Is Yaron Ilan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Yaron Ilan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice (2010) (300)
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. (2006) (263)
Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. (1997) (210)
Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. (2012) (183)
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. (2002) (164)
Treatment of Chronic Hepatitis C Virus Infection via Antioxidants: Results of a Phase I Clinical Trial (2005) (135)
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. (1997) (133)
Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. (1993) (129)
Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. (1996) (116)
Adoptive transfer of immunity to hepatitis B virus after T cell–depleted allogeneic bone marrow transplantation (1993) (115)
Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. (1994) (112)
Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period* (1996) (111)
Liver‐associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model (1999) (107)
Adoptive transfer of regulatory NKT lymphocytes ameliorates non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping (2006) (107)
Transient immunosuppression with FK506 permits long‐term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat (1997) (106)
Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis: A Study of 68 Patients (2002) (105)
A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. (2000) (96)
β-Glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders (2006) (94)
Oral tolerization to adenoviral proteins permits repeated adenovirus‐mediated gene therapy in rats with pre‐existing immunity to adenoviruses (1998) (91)
Cannabidiol improves brain and liver function in a fulminant hepatic failure‐induced model of hepatic encephalopathy in mice (2011) (88)
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation (2001) (83)
Adenovirus-mediated gene therapy of liver diseases. (1999) (83)
Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells (2009) (74)
Glucocerebroside Ameliorates the Metabolic Syndrome in OB/OB Mice (2006) (71)
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. (2005) (71)
Liver abscess in inflammatory bowel disease: Report of two cases and review of the literature (2004) (69)
Hepatitis C virus viremia in SCID-->BNX mouse chimera. (1995) (66)
Glycolipids as immune modulatory tools. (2006) (64)
Review article: the assessment of liver function using breath tests (2007) (63)
Oral administration of immunoglobulin G‐enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells (2012) (63)
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH (2012) (63)
Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat. (2009) (63)
Case series: hyponatremia associated with moderate exercise. (1996) (62)
NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen‐pulsed dendritic cells (2003) (61)
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial (2015) (61)
Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes (2000) (60)
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice (2006) (60)
A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT (2008) (58)
Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients (2000) (57)
Schönlein-Henoch syndrome in adults and children. (1991) (56)
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C. (2011) (55)
Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial. (2007) (55)
p53 expression in patients with cirrhosis with and without hepatocellular carcinoma (1995) (53)
Vasculitis and cryoglobulinemia associated with persisting cholestatic hepatitis A virus infection. (1990) (53)
Hepatic hydrothorax – pathophysiology, diagnosis and treatment – review of the literature (2004) (52)
Microtubules: From understanding their dynamics to using them as potential therapeutic targets (2018) (50)
Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins (2003) (50)
β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems (2019) (48)
Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance. (2016) (48)
Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors (1993) (47)
Amelioration of non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver‐extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL‐10 levels (2006) (47)
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP‐activated protein kinase (2007) (47)
Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone. (2004) (47)
Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. (2006) (47)
Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus. (1995) (46)
Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice (2000) (46)
A Double-Blind Clinical Trial for Treatment of Crohn's Disease by Oral Administration of Alequel™, A Mixture of Autologous Colon-Extracted Proteins: A Patient-Tailored Approach (2006) (46)
Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors (1994) (46)
Hepatitis B virus infection associated with hematopoietic tumors. (1994) (45)
Generating randomness: making the most out of disordering a false order into a real one (2019) (45)
The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy (2019) (43)
Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents (2020) (43)
Endocannabinoids and liver disease – review (2005) (42)
Alleviation of Acute and Chronic Graft-Versus-Host Disease in a Murine Model Is Associated with Glucocerebroside-Enhanced Natural Killer T Lymphocyte Plasticity (2007) (42)
Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice (2008) (41)
The gut mucosa as a site for induction of regulatory T-cells. (2009) (41)
A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment (2019) (40)
Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation? (2019) (39)
Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies (2019) (39)
The gut‐kidney axis in chronic renal failure: A new potential target for therapy (2017) (39)
Late cytomegalovirus disease following liver transplantation (2002) (39)
Suppression of hepatocellular carcinoma by transplantation of ex‐vivo immune‐modulated NKT lymphocytes (2005) (38)
Randomness in microtubule dynamics: an error that requires correction or an inherent plasticity required for normal cellular function? (2019) (38)
Immunomodulation of experimental colitis via caloric restriction: role of Nk1.1+ T cells. (2002) (38)
Oral tolerance: can we make it work? (2009) (34)
Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. (2007) (34)
Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent (2009) (34)
Review article: novel methods for the treatment of non‐alcoholic steatohepatitis – targeting the gut immune system to decrease the systemic inflammatory response without immune suppression (2016) (34)
Massive repopulation of rat liver by transplantation of hepatocytes into specific lobes of the liver and ligation of portal vein branches to other lobes. (1997) (34)
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase. (2015) (34)
Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats. (2006) (34)
Is presensitization relevant to liver transplantation outcome? (2002) (33)
Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes (2005) (33)
NK 1.1+ T Cell: A Two-Faced Lymphocyte in Immune Modulation of the IL-4/IFN-γ Paradigm (2002) (32)
The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis (2015) (32)
A multicentre, randomized study to evaluate the safety and efficacy of histamine dihydrochloride and interferon‐α‐2b for the treatment of chronic hepatitis C (2002) (31)
Adoptive transfer of ex vivo immune‐programmed NKT lymphocytes alleviates immune‐mediated colitis (2004) (31)
Reactions of the ferri-ferrocytochrome-c system with superoxide/oxygen and CO2-/CO2 studied by fast pulse radiolysis. (1976) (31)
Reactions of the ferri-ferrocytochrome-c system with superoxide/oxygen and CO2-/CO2 studied by fast pulse radiolysis. (1976) (31)
Advanced Tailored Randomness: A Novel Approach for Improving the Efficacy of Biological Systems (2020) (31)
Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease (2016) (31)
Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model (2000) (31)
Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice (2009) (31)
Immunotherapy with oral administration of humanized anti‐CD3 monoclonal antibody: a novel gut‐immune system‐based therapy for metaflammation and NASH (2018) (31)
Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination. (2008) (30)
Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients (2010) (30)
Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy (2020) (30)
Reduced liver cell death using an alginate scaffold bandage: a novel approach for liver reconstruction after extended partial hepatectomy. (2014) (30)
Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens – bystander effect (2001) (29)
Gastric stimulation for weight loss. (2012) (29)
Induction of oral immune regulation towards liver‐extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial (2004) (29)
Liver involvement in Gaucher disease - Review and clinical approach. (2018) (29)
Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. (2009) (28)
Personalized inherent randomness of the immune system is manifested by an individualized response to immune triggers and immunomodulatory therapies: a novel platform for designing personalized immunotherapies (2019) (28)
Resistance of hepatitis delta virus replication to interferon-alpha treatment in transfected human cells. (1992) (28)
Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect. (2001) (28)
Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. (1995) (27)
A Novel 13C-Urea Breath Test Device for the Diagnosis of Helicobacter pylori Infection: Continuous Online Measurements Allow for Faster Test Results With High Accuracy (2003) (27)
Induction of oral tolerance towards hepatitis B envelope antigens in a murine model. (2000) (27)
Adropin as a potential mediator of the metabolic system‐autonomic nervous system‐chronobiology axis: Implementing a personalized signature‐based platform for chronotherapy (2020) (27)
Postpartum Budd-Chiari syndrome with prolonged hypercoagulability state. (1990) (27)
Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects (2020) (27)
Order Through Disorder: The Characteristic Variability of Systems (2020) (26)
Oral anti‐CD3 immunotherapy for HCV‐nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase‐2a placebo‐controlled trial (2015) (26)
Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin. (1993) (26)
The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs (2020) (26)
The role of microtubules in the immune system and as potential targets for gut-based immunotherapy. (2019) (26)
Overcoming randomness does not rule out the importance of inherent randomness for functionality (2019) (26)
Immunization against hepatitis B through adoptive transfer of immunity. (1995) (25)
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model (2014) (25)
Enzyme replacement therapy for mild patients with Gaucher disease (2009) (25)
Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function-associated Multi-organ Autoimmune Syndrome. (2017) (25)
Suppression of Hepatocellular Carcinoma Growth via Oral Immune Regulation towards Tumor-Associated Antigens Is Associated with Increased NKT and CD8+ Lymphocytes (2004) (25)
Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model. (2000) (25)
The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. (2004) (25)
Enhancement of immune tolerance via induction of NK1.1 positive liver-associated-lymphocytes under immunosuppressive conditions. (2000) (25)
Erythrocytosis after renal transplantation. The response to theophylline treatment. (1994) (25)
Primary Sclerosing Cholangitis in Sarcoidosis (1993) (24)
The study of 1-electron equivalent oxidation-reduction reactions by fast pulse generation of reagents. Cytochrome c/ferri-ferrocyanide system. (1976) (24)
Modulation of intracellular machinery by beta-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis. (2008) (24)
Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping. (2008) (24)
Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases (2021) (24)
Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization. (1994) (23)
Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes (2020) (23)
Vascular complications post orthotopic liver transplantation. (1999) (22)
Liver involvement in giant cell arteritis (1993) (22)
Induction of immune tolerance: a role for Natural killer T lymphocytes? (2005) (22)
Acute pericarditis: etiology, treatment and prognosis. A study of 115 patients. (1991) (22)
Oral Administration of β-Glucosylceramide for the Treatment of Insulin Resistance and Nonalcoholic Steatohepatitis: Results of a Double-Blind, Placebo-Controlled Trial. (2017) (21)
Beta Glycosphingolipids Suppress Rank Expression and Inhibit Natural Killer T Cell and CD8+ Accumulation in Alleviating Aortic Valve Calcification (2009) (21)
Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2. (2009) (21)
NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids. (2008) (21)
Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells? (2005) (21)
Hepatitis-C-associated cryoglobulinemia after liver transplantation. (1995) (20)
An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy. (2017) (20)
Chronic hepatitis C virus infection with exposure to hepatitis B virus. (1994) (20)
Role of the Immune System and the Circadian Rhythm in the Pathogenesis of Chronic Pancreatitis: Establishing a Personalized Signature for Improving the Effect of Immunotherapies for Chronic Pancreatitis. (2020) (20)
Partitioning of electrostatic and conformational contributions in the redox reactions of modified cytochromes c. (1979) (19)
Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigen. (1997) (19)
Immune downregulation leads to upregulation of an antiviral response: a lesson from the hepatitis B virus. (2002) (19)
Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance. (2015) (19)
A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis. (2017) (18)
Induction of immune tolerance toward tumor‐associated‐antigens enables growth of human hepatoma in mice (2002) (18)
Familial cluster of fulminant hepatitis A infection. (2001) (18)
Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus. (1996) (18)
Oral administration of non‐absorbable delayed release 6‐mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial (2015) (18)
REDUCED INCIDENCE OF HYPERURICEMIA, GOUT, AND RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION IN COMPARISON TO HEART TRANSPLANTATION: A LONG-TERM FOLLOW-UP STUDY (2004) (18)
The coexistence of Sweet's syndrome and Still's disease--is it merely a coincidence? (2004) (18)
Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor (2021) (18)
Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation. (2015) (18)
Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial. (2005) (18)
Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells? (2009) (18)
Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice (2002) (17)
Utility of a 13C‐methacetin breath test in evaluating hepatic injury in rats (2008) (17)
Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm (2021) (17)
MALIGNANT MELANOMA IN TURNER'S SYNDROME (1993) (17)
Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis (2016) (17)
Increased serum CA 19-9 antibodies in Sjögren's syndrome. (1998) (17)
Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance. (2020) (16)
Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. (2007) (16)
Malignancy After Liver Transplantation in Patients With Premalignant Conditions (2003) (16)
Effects of alcohol/water mixtures on the structure and reactivity of cytochrome c. (1978) (16)
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. (2008) (15)
Evaluation of the 13C-Octanoate Breath Test as a Surrogate Marker of Liver Damage in Animal Models (2010) (15)
β‐Glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis (2009) (15)
Gastrointestinal involvement in homocystinuria (1993) (15)
Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift (2017) (15)
Decreased STAT-1 phosphorylation by a thio analogue of beta-D-glucosylceramide is associated with altered NKT lymphocyte polarization. (2009) (14)
IgA deficiency associated with chronic hepatitis C virus infection. A cause or an effect? (1993) (14)
Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development. (2018) (14)
β-Glycosphingolipids as Immune Modulators (2008) (14)
Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model (2003) (14)
Etiology, treatment, and prognosis of large pericardial effusions. A study of 34 patients. (1991) (14)
A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage (2021) (14)
Role of circadian rhythm and autonomic nervous system in liver function: a hypothetical basis for improving the management of hepatic encephalopathy. (2021) (14)
Extracts from Lentinula edodes (Shiitake) Edible Mushrooms Enriched with Vitamin D Exert an Anti-Inflammatory Hepatoprotective Effect. (2016) (14)
The Role of Sphingolipid Pathway in Liver Fibrosis: An Emerging New Potential Target for Novel Therapies. (2020) (14)
Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic? (2017) (14)
Oral Immune Regulation toward Disease‐Associated Antigens: Results of Phase I Clinical Trials in Crohn's Disease and Chronic Hepatitis (2004) (14)
Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation. (1996) (13)
Oral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trial. (2015) (13)
Towards a bank of cryopreserved hepatocytes: which cell to freeze? (2002) (13)
Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity. (2021) (13)
Treatment of experimental colitis through induction of oral tolerance towards colitis-extracted proteins (1998) (13)
Sanctuary of hepatitis B virus in bone-marrow cells of patients undergoing liver transplantation. (1996) (13)
Establishment of an Individualized Chronotherapy, Autonomic Nervous System, and Variability-Based Dynamic Platform for Overcoming the Loss of Response to Analgesics. (2021) (13)
Assessment of liver function in acute or chronic liver disease by the methacetin breath test: a tool for decision making in clinical hepatology (2009) (12)
The Economics of Software Distribution over the Internet Revisited (2001) (12)
A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative Review (2022) (12)
Immune rebalancing by oral immunotherapy: A novel method for getting the immune system back on track (2018) (12)
Solid tumors after liver transplantation. (1999) (12)
Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking. (2006) (12)
Regulatory Role of the Pituitary‐Adrenal Axis in Experimental Colitis: Effect of Adrenalectomy on the Clinical Course and the TH1/TH2 Immune Profile (2005) (12)
A critical role of the liver in inducing oral tolerance to adenoviral vectors for long-term gene therapy (1998) (12)
Primary biliary cirrhosis in Israel. (1992) (11)
Immune therapy for nonalcoholic steatohepatitis: are we there yet? (2013) (11)
Cavoatrial shunt: a graft salvage procedure for suprahepatic caval anastomosis obstruction after liver transplantation. (1998) (11)
A fourth dimension in decision making in hepatology (2010) (11)
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment. (2001) (11)
Immunogenicity of a Mammalian Cell-derived Recombinant Hepatitis B Vaccine Containing Pre S2 and Pre S1 Antigens: A Preliminary Report (1994) (11)
Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells (2013) (11)
Pregnancy and liver transplantation. (1999) (11)
H/2H isotope effect in redox reactions of cytochrome c. (1977) (11)
Role of NK1.1+ and AsGm-1+ Cells in Oral Immunoregulation of Experimental Colitis (2003) (11)
Administration of beta-glycolipids overcomes an unfavorable nutritional dependent host milieu: a role for a soy-free diet and natural ligands in intrahepatic CD8+ lymphocyte trapping and NKT cell redistribution. (2008) (10)
Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis (2020) (10)
Early expression of interferon gamma following oral antigen administration is associated with peripheral tolerance induction. (2003) (10)
Glomerulonephritis associated with acute HAV infection. (1992) (10)
Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model (2017) (10)
Plasma and tumor prolactin in colorectal cancer patients (1995) (10)
Impaired liver regeneration is associated with reduced cyclin B1 in natural killer T cell-deficient mice (2017) (10)
Endocannabinoids and liver disease. Liver Int 25: 921-8 (2005) (10)
Henoch Schonlein purpura in children and adults: is it one entity? (2002) (10)
Hepatitis A and Other Viral Infections (2020) (10)
1047 Glucocerebroside induces altered anti hepatitis C immunity in patients with Gaucher's disease (2003) (10)
Induction of tolerance to hepatitis B virus: can we 'eat the disease' and live with the virus? (1999) (10)
Prevention of acetaminophen‐induced liver injury by alginate (2019) (10)
Immune therapy for hepatocellular carcinoma (2014) (9)
Undetectable caeruloplasmin values in a patient with autoimmune chronic active hepatitis. (1991) (9)
Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response (2022) (9)
Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment (2018) (9)
Exacerbation of pulmonary sarcoidosis after liver transplantation. (2002) (9)
Improving the long-term response to antidepressants by establishing an individualized platform based on variability and chronotherapy. (2021) (9)
Short-Term Cohousing of Sick with Healthy or Treated Mice Alleviates the Inflammatory Response and Liver Damage (2020) (9)
Intramolecular electron transfer and binding constants in iron hexacyanide-cytochrome c complexes as studied by pulse radiolysis. (1979) (9)
Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects (2022) (8)
Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect. (2005) (8)
In vivo CAMPATH-1 followed by T cell-depleted bone marrow transplantation: a potential new mode of therapy for hepatitis-associated severe aplastic anemia (SAA). (1996) (8)
Major neurological complications following liver transplantation. (2001) (8)
Pericarditis Associated with High-Dose Cytarabine Therapy for Acute Myeloblasts Leukemia: a Rare Complication of Therapy (1992) (8)
Oral immune regulation: a novel method for modulation of anti-viral immunity. (2004) (8)
Primary sclerosing cholangitis and liver transplantation. (1999) (8)
NK 1.1+ T cell: a two-faced lymphocyte in immune modulation of the IL-4/IFN-gamma paradigm. (2002) (8)
DisseminatedNocardia transvalensis infection resembling pulmonary infarction in a liver transplant recipient (1995) (8)
Primary sclerosing cholangitis is associated with abnormalities in CFTR. (2018) (8)
Bilirubin Metabolism and Hyperbilirubinemia (1998) (8)
The role of ERCP in biliary complications after liver transplantation. (1999) (8)
and weight-based ribavirin in patients with genotype (2011) (8)
Pyrexia of unknown origin as the only manifestation of colorectal carcinoma. (1992) (7)
Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs. (2004) (7)
Mixed connective tissue disease presenting as a left sided pleural effusion. (1992) (7)
Intrahepatic CD8(+) lymphocyte trapping during tolerance induction using mushroom derived formulations: a possible role for liver in tolerance induction. (2008) (7)
Effect of peripheral immune tolerance on liver-associated lymphocytes expressing NK1.1. (2000) (7)
Reoperation after liver transplantation. (1999) (7)
Recurrent transient bone marrow hypoplasia associated with pregnancy. (1993) (7)
Air transportation of patients with end‐stage liver disease to distant liver transplantation centers (2005) (7)
Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury (2018) (7)
[Neurologic complications following liver transplantation]. (2002) (7)
Hepatitis C-associated cryoglobulinemia presenting with pericardial effusion. (1997) (6)
Reversible hepatic injury induced by long-term vitamin A ingestion. (1992) (6)
A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders. (2020) (6)
Review: Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn’s disease (2010) (6)
Pleural effusion--the presenting radiological manifestation of sarcoidosis. (1994) (6)
Porogen derived membranes. 1. Concept description and analysis (1990) (6)
Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases (2022) (6)
Tu2029 A novel method for anti-TNF based-oral immunotherapy: Oral administration of a plant cell-expressed recombinant anti-TNF fusion protein for treating of Crohn's disease (2014) (6)
Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need? (2018) (6)
Impaired liver regeneration by β‐glucosylceramide is associated with decreased fat accumulation (2013) (5)
The constrained disorder principle defines living organisms and provides a method for correcting disturbed biological systems (2022) (5)
Adoptive transfer of immunity to hepatitis B : development of the concept and evolution of the research project for targeted immunotherapy against hepatic cells which express a viral antigen (1995) (5)
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus (1997) (5)
Hepatic failure associated with imipramine therapy. (1996) (5)
Microtubules as a potential platform for energy transfer in biological systems: a target for implementing individualized, dynamic variability patterns to improve organ function (2022) (5)
The role of bacterial translocation in sepsis: a new target for therapy (2022) (5)
Oral immune regulation: a new mode of therapy against chronic viral infections. (2007) (5)
Improved immunogenicity in mice of a recombinant hepatitis B vaccine containing preS1 and preS2 antigens in HBs particles (1991) (5)
[Surgical intervention in infective endocarditis: indications and timing]. (2005) (5)
Pulmonary embolism as the presenting feature of hepatocellular carcinoma. (1994) (5)
Antibody response to SARS-Co-V-2, diagnostic and therapeutic implications. (2020) (5)
640 Alleviation of ConA immune mediated hepatitis via glycolipids: The role of beta versus alpha configuration in determining NKT lymphocyte distribution and the TH1/TH2 paradigm (2006) (4)
[Hepatorenal syndrome: pathogenesis and treatment]. (2007) (4)
144 REDUCED DOSE AND DURATION OF PEGINTERFERON ALFA-2B + WEIGHT-BASED RIBAVIRIN IN EUROPEAN AND ASIAN GENOTYPE 2 AND 3 CHRONIC HEPATITIS C PATIENTS (REDD 2/3 TRIAL) (2009) (4)
[Budd-Chiari syndrome: updated treatment modalities]. (2004) (4)
Late cytomegalovirus infection occurring two or more years following liver transplantation: a report of seven cases and review of the literature. (2003) (4)
[Hepatic and hematological complications following ecstasy usage]. (2001) (4)
Oral tolerance: a new tool for the treatment of gastrointestinal inflammatory disorders and liver-directed gene therapy. (1999) (4)
Reversal of fulminant-hepatitis-associated hypoglycaemia at the anhepatic stage during liver transplantation. (1996) (4)
Natural course of de novo hepatitis B virus infection in liver transplant recipients. (1997) (4)
Idiopathic liver involvement in Turner syndrome. (2004) (4)
Impaired liver function tests in patients treated with antithymocyte globulin: Implication for liver transplantation (1997) (4)
Disseminated Nocardia transvalensis infection resembling pulmonary infarction in a liver transplant recipient. (1995) (3)
The assembly of glycosphingolipid determines their immunomodulatory effect: A novel method for structure-based design of immunotherapy. (2020) (3)
30 ACUTE LIVER FAILURE: CURRENT EUROPEAN PERSPECTIVE (2010) (3)
Late Relapse in Hodgkin's Disease: Report of Five Cases and a Review of the Literature. (1991) (3)
Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized rats. (2003) (3)
739 - A Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Mild to Moderate Ulcerative Colitis: Results of a Phase 2A Clinical Trial Showing Promising Results (2018) (3)
The role of NK1.1+ liver associated lymphocytes in peripheral immunemodulation of experimental colitis via oral tolerance or diet restriction (2001) (3)
[Transfusion-related acute lung injury]. (1993) (3)
Elevated growth hormone levels in patients with non‐alcoholic chronic liver disease (1993) (3)
Combination therapy for hepatitis C virus reinfection after orthoptic liver transplantation. (2001) (3)
Viral Diseases of the Liver (2013) (3)
A balanced 5:1 carbohydrate : protein diet: A new method for supplementing protein to patients with chronic liver disease (2000) (3)
[Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?]. (2003) (2)
Variable efficacy of interferon-alpha treatment on growth of human hepatoma cell lines in vitro. (1988) (2)
Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms (2022) (2)
Making use of noise in biological systems. (2023) (2)
Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation? (1997) (2)
Hepatitis C-associated cryoglobulinemia after liver transplantation. (1995) (2)
Biomarkers for Nonalcoholic Steatohepatitis. (2018) (2)
Bone mineral density after liver transplantation. (2001) (2)
Personalized-Inherent Variability in a Time-Dependent Immune Response: A Look into the Fifth Dimension in Biology (2022) (2)
Alpha-1 Anti-trypsin Exerts a Hepatoprotective Effect on Immune-mediated Hepatitis and Acetaminophen-induced Liver Injury (2018) (2)
Oral immune regulation using colitis extracted proteins—A new model of treatment of Crohn's disease: Results of a phase I clinical trial (2003) (2)
Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections (2023) (2)
Augmented antiviral T cell immunity by oral administration of IMM‐124E in preclinical models and a phase I/IIa clinical trial: A method for the prevention and treatment of COVID‐19 (2021) (2)
Long-term prevention of recurrent hepatitis B virus after liver transplantation. (1995) (2)
Correlations between components of the immune system (2021) (2)
A novel method & device for Helicobacter pylori detection: Continuous, fast 13C-Urea breath test (1998) (2)
16 Glucocerebroside treatment ameliorates CON-A hepatitis by inhibition of NKT lymphocytes: a new immunemodulatory tool (2003) (2)
Technology evaluation: naked DNA. (1999) (2)
Histamine dihydrochloride: actions and efficacy in the treatment of chronic hepatitis C infection (2006) (2)
Long-Term Efect of Short-Term Oral Administration of A Mixture of Autologous Proteins Extracted From The Colon of Patients with Crohn's Disease: A Memory Effect of Oral Tolerance Induction (2015) (2)
TT Virus Infection in Israeli Patients with Fulminant Hepatic Failure (2000) (2)
[Idiopathic right-sided endocarditis: an uncommon manifestation of pulmonary cavitations]. (2009) (1)
Acute liver failure: a European perspective (2010) (1)
The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways (2021) (1)
692 Adoptive transfer of regulatory NKT lymphocytes ameliorates steatohepatitis and glucose intolerance in leptin-deficient mice (2003) (1)
S1837 The Point of Care 13C Methacetin Breath Test Accurately Predicts Long Term Prognosis in Patients with Chronic Liver Disease: A Non Invasive Liver Function Test (2009) (1)
54 Suppression of hepatocellular carcinoma by transplantation of immune-modulated NKT lymphocytes is associated with STAT4 expression and a TH1 immune response (2003) (1)
Pregnancy rate and embryo loss in the NK1.1+ T cell-depleted mouse. (2001) (1)
Irregular External Gastric Stimulation is Associated with Suppression of Serum Ghrelin Levels and Prolonged Decrease in Weight: A Novel Method for Sustaining Weight Loss (2016) (1)
Use of an on-line at the point of care 13C-Methacetin Breath test as an adjunct tool for decision making in patients with Acute Liver Failure (2012) (1)
Oral Administration of Hoodia parviflora Alleviates Insulin Resistance and Nonalcoholic Steatohepatitis. (2019) (1)
Prenatal tolerization to recombinant adenovirus permits long-term correction of bilirubin glucuronidation defect in Gunn rats by repeated adenovirus-mediated gene therapy (1998) (1)
Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach (2021) (1)
A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial. (2023) (1)
Long term liver directed gene therapy by downregulating the anti adenovirus Th1 immune response (1998) (1)
Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis (2002) (1)
13C-methacetin breath test is a highly accurate non-invasive point of care test for detecting CSPH in patients with NASH (2018) (1)
T1198 Oral Administration of Alequel™, a Mixture of Autologous Colon-Extracted Proteins for Treatment of Crohn's Disease: Results of a Double-Blind Clinical Trial (2009) (1)
Prolonged course of a cutaneous T‐cell lymphoma with late systemic involvement (1990) (1)
[Reduced-size liver transplants in children]. (1994) (1)
Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent (2022) (1)
Asian and White Patients With Chronic Hepatitis C (CHC) Achieve Similar Response Rates With Peginterferon (PEG-IFN) Alfa-2b Plus Ribavirin (RBV) in Genotypes (G) 2 and 3: Subanalysis of the REDD 2/3 Study (2009) (1)
Premalignant conditions: risk factor for postliver transplantation malignancy. (2001) (1)
Induction of oral tolerance enables growth of hepatoma cell line in mice (2000) (1)
Enhancing the plasticity, proper function and efficient use of energy of the Sun, genes and microtubules using variability (2022) (1)
Subacute cutaneous lupus associated with Hashimoto's thyroiditis. (1991) (1)
The 13C‐methactin breath test is non‐inferior to liver biopsy in predicting liver‐related death and transplantation: A 7‐year prospective follow‐up study in 132 patients with chronic hepatitis C infection (2020) (1)
1202 ORAL ANTI-CD3 IMMUNOTHERAPY FOR HCV-NON-RESPONDERS IS SAFE, PROMOTES REGULATORY T CELLS, AND DECREASES VIRAL LOAD AND LIVER ENZYME LEVELS: RESULTS OF A PHASE-2a PLACEBO-CONTROLLED TRIAL (2013) (1)
74 Amelioration of non-alcoholic steatohepatitis and glucose intolerance in OB/OB mice via oral immune regulation towards liver extracted proteins is associated with elevated intrahepatic NKT lymphocytes and a TH2 immune shift (2003) (1)
[Idiopathic hypereosinophilic syndrome]. (1993) (1)
A synergistic effect of Cremophor and beta glucosylceramide to exert liver and sugar protection (2017) (1)
141 Anti-fibrotic activity of NK cells in experimental liver injury through enhanced activation combined with increased susceptibility of activated HSC's to killing (2003) (1)
Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications (2020) (1)
Oral tolerance for treatment of GI inflammation (2004) (1)
Elevated creatine phosphokinase and creatine phosphokinase-MB in acute laryngitis. (1991) (0)
[Reorganization of the Department of Medicine--how we should respond to the changes in internal medicine]. (2008) (0)
Oral immune regulation of anti-viral immunity (2004) (0)
Downregulation of a tumor promotion immune response via induction of oral tolerance towards tumor-associated-antigens: can we 'eat the tumor'? (2001) (0)
[Interrelation between liver and bowel involvement in ulcerative colitis patients undergoing liver transplantation]. (1993) (0)
41 ORAL ADMINISTRATION OF ANTI CD3-MONOCLONAL ANTIBODIES PROMOTES CD4+CD25+ LAP+ AND NKT LAP+ REGULATORY T LYMPHOCYTES AND AMELIORATES HEPATITIS BY INHIBITING CASPASE 3-MEDIATED APOPTOSIS (2009) (0)
Irreversible inhibition of ornithine aminotransferase mediates hepatocellular carcinoma suppression is a result of inhibition of glutamine and beta-catenin and suppression of regulatory T cells: a novel mechanism for treatment of primary liver cancer (2017) (0)
651 Intrahepatic CD4+ lymphocytes trapping during tolerance induction using mushroom derived formulations: A possible role for the liver in tolerance induction (2006) (0)
Correction of β-glucuronidase deficiency in mice by intrasplenic transplantation of isolated hepatocytes (1995) (0)
M1264 The Non-Invasive 13C Octanoate Breath Test Accurately Assesses Hepatic Mitochondrial Beta Oxidation Before and After Bariatric Surgery (2009) (0)
Primary Greater Omental Torsion : CT Diagnosis in an Elderly Woman (2003) (0)
460 The 13c Methacetin Breath Test Accurately Identifies Liver Fibrosis in Patients with Chronic Hepatitis C Virus Infection: A Validation Study (2008) (0)
[Neurological manifestations of non A-G viral hepatitis]. (1999) (0)
' s response to reviews Title : Assessment of insulin resistance by a 13 C glucose breath test : a new tool for early diagnosis and follow-up of high-risk patients (2010) (0)
T1241 Promotion of CD4+CD25+FOXP3+ Regulatory Cells by Oral Administration of Locally Acting Delayed Release Low-Dose 6MP Formulation Alleviated Crohn's Disease: Results of Phase I/II Clinical Trial (2010) (0)
Clinical Correlates of Early IgG Response in Patients with Mild COVID-19 (2020) (0)
Abstract PO001: Preclinical activity of glypican-3 (GPC3) and NKp46 directed FLEX-NK™ engager antibody (CYT-303) in combination with iPSC derived natural killer cells (iNKs) or peripheral blood (PB) NK cells in hepatocellular carcinoma (HCC) (2022) (0)
OR.104. Induction of Regulatory T Cells by Mucosal Administration of Aryl Hydrocarbon Receptor Ligands and Anti-CD3 Monoclonal Antibody in Animals and Humans (2009) (0)
[Inflammatory bowel disease--infectious, environmental, genetic and immune mechanisms of pathogenesis]. (2000) (0)
Circadian rhythm of successful resuscitation attempts. (1988) (0)
Colostrum-derived immunoglobulin preparation comprising anti-insulin antibodies for the treatment of metabolic syndrome (2009) (0)
[778] AMELIORATION OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND THE METABOLIC SYNDROME IN DIABETIC COHEN RATS IS ASSOCIATED WITH REDUCED PANCREATIC INJURY (2007) (0)
ResearchAssessment of insulin resistance by a 13 C glucose breath test : a new tool for early diagnosis and follow-up of high-risk patients (2015) (0)
[362] OPTIMIZATION OF BETA-GLYCOLIPID STRUCTURE FOR SUPPRESSION OF HEPATOCELLULAR CARCINOMA IN MICE: A ROLE FOR THE SPHINGOSINE CHAIN LENGTH IN ALTERING NKT LYMPHOCYTE-ASSOCIATED ANTI-TUMOR EFFECT (2007) (0)
[Hepatitis E virus infection]. (1994) (0)
Large solitary splenic diffuse large B cell lymphoma in a hepatitis C virus-infected patient. (2005) (0)
Papaverine-induced coma (2004) (0)
742 ACCURATE IDENTIFICATION OF LIVER FIBROSIS IN CHRONIC HCV PATIENTS USING A CONTINUOUS 13C METHACETIN BREATH TEST: A VALIDATION STUDY OF A NOVEL DECISION MAKING TOOL (2008) (0)
Oxidation reaction of ferrocytochrome C by ferricyanide as a probe to effects of alcohols on structure and reactivity of the protein. Technical progress report (1977) (0)
15 Redistribution of intrahepatic NKT regulatory lymphocytes via administration of beta glycolipids: A possible role for the liver in the alleviation of immune-mediated disorders (2006) (0)
Manifestations of Inherited Disorders of Bilirubin Glucuronidation During Infancy and Childhood (1998) (0)
The course of hepatitis B virus after liver transplantation. (2000) (0)
The potential role of Î²-glycosphingolipids in the immune system: Novel secondary messengers (2015) (0)
Glucocerebroside Alleviates Chronic Graft-Versus-Host-Disease in a Murine Model. (2004) (0)
Prophylactic lamivudine therapy may prevent immunosuppressive induced HBV reactivation in chronic carriers (2001) (0)
Contents Vol. 79, 2000 (2000) (0)
Iron hexacyanide/cytochrome-C - intramolecular electron transfer and binding constants - (pulse radiolytic study). Progress report (1980) (0)
Liver transplantation for patients with hepatitis delta infection. (1993) (0)
The point of care 13C-Methacetin Breath Test predicts risk of long-term liver-related death or transplantation in patients with chronic liver disease: a sensitive, noninvasive monitoring tool in clinical hepatology (2017) (0)
Resistance of delta virus replication to interferon alpha treatment in transfected human cells (1991) (0)
Internal electron transfer within mitochondrial succinate-cytochrome c reductase. (1978) (0)
13C-Methacetin Breath Test accurately assesses clinically significant portal hypertension in patients with NASH cirrhosis (2017) (0)
Retraction of: Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. (2011) (0)
Methacetin Breath Test is Superior to Meld in Predicting Mortality in Patients with Acute on Chronic Liver Failure: Results of a Phase II Clinical Trial (2016) (0)
362 13C BREATH TEST IDENTIFIES DECREASED BETA-OXIDATION, IMPROVED GLUCOSE TOLERANCE AND HEPATIC IMPAIRMENT IN PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS AFTER AN EXERCISE AND DIET INTERVENTION (2010) (0)
[Prognostic and diagnostic values of exercise stress in asymptomatic subjects]. (1985) (0)
(Marijuana/Hash) Endocannabinoids and liver disease - review (0)
An Immune Modulatory Effect by Oral Co-Administration of Soy-Derived Extracts with High Alcohol or Sugar-Sweetened Beverages Exerts Liver and Sugar Protective Effects (2016) (0)
Induction of oral tolerance prior to or following bone marrow transplantation ameliorates chronic graft versus host disease in a murine model (2000) (0)
STAT3-gain of function mutation as a cause of severe bronchiectasis and multi-organ autoimmunity; A case report (2016) (0)
[Solid organ retransplantation]. (1997) (0)
Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation. (2023) (0)
Assessing interventions and symptoms following early administration of streptokinase for acute myocardial infarction. (1988) (0)
Corrigendum: Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice (2009) (0)
Oral formulation of metadoxin (2008) (0)
Intravenous verapamil for tachyarrhythmia in Duchenne's musdcular dystrophy (1990) (0)
Competition Law and High-Tech Markets : Conventional Antitrust Thinking Revisited? (2007) (0)
756P Glypican-3 (GPC3) and NKp46 directed FLEX-NK engager antibody (CYT-303) recruits natural killer (NK) cells to tumors in a preclinical hepatocellular carcinoma (HCC) mouse model (2022) (0)
The administration of gliadin downregulates the intraepithelial lymphocytosis induced by a rectal gluten challenge. (2003) (0)
[Place of residence in Jerusalem as a prognostic factor in out-of hospital resuscitation]. (1987) (0)
P511 USE OF C-METHACETIN BREATH TEST (MBT) TO PREDICT CIRRHOSIS COMPLICATIONS AND MORTALITY IN PATIENTS WITH LOW MELD SCORES EVALUATED OR LISTED FOR LIVER TRANSPLANTATION (LT) (2014) (0)
P298 ACETAMINOPHEN (APAP) FORMULATIONS CONTAINING METHYL-SULFONYL-METHANE AND ISOSILYBIN B AMELIORATE APAP-MEDIATED LIVER TOXICITY WHILE RETAINING APAP EFFICACY (2014) (0)
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial (2015) (0)
T cell, B cell and natural killer cell function of patients with chronic hepatitis C virus infection (1996) (0)
Oral Tolerance for IBD (2006) (0)
Adoptive Transfer of Immunity to Hepatitis B Through Bone Marrow Transplantation from Immunized Donors (1994) (0)
Constrained disorder principle-based variability is fundamental for biological processes: Beyond biological relativity and physiological regulatory networks. (2023) (0)
Mo1881 Oral Administration of a Recombinant Anti-TNF Fusion Protein Is Biologically Active in the Gut Promoting Regulatory T Cells and Is a Novel Anti-TNF Alpha-Based Therapy for Inflammatory Bowel Diseases: Results of a Phase I Clinical Trial (2016) (0)
Expression of P53 in cirrhotic livers adjacent to hepatocellular carcinoma (1994) (0)
Elucidation of the role of microRNA-155 in a murine model of non-alcoholic steatohepatitis Autoimmune Hepatitis in Denmark: Incidence, preva-lence and prognosis. A nationwide registry-based cohort study (2013) (0)
Subject Index Vol. 79, 2000 (2000) (0)
A digital health platform for assisting in diagnosing and monitoring disease progression of COVID-19: An adjuvant approach for augmenting the anti-viral response and reducing the immune-mediated target organ damage (Preprint) (2020) (0)
Sulfatides for the treatment of autoimmune disorders (2007) (0)
[Hepatitis C virus infection and primary mixed cryoglobulinemia]. (1996) (0)
Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance (2022) (0)
The role of NK1.1+ liver-associated lymphocytes in peripheral immunemodulation via diet restriction (2001) (0)
Why scientists, academic institutions, and investors fail in bringing more products to the bedside: the Active Compass model for overcoming the innovation paradox (2021) (0)
Constrained disorder principle-based second-generation algorithms implement quantified variability signatures to improve the function of complex systems (2023) (0)
Microbial triggers for inflammatory disease (SY6-2) Chairpersons: Kiyoshi Takeda, Hilde Cheroutre (2010) (0)
PERIPHERAL IMMUNE TOLERANCE INDUCES LIVER ASSOCIATED-LYMPHOCYTES EXPRESSING NK1.1 (1999) (0)
Dendritic cells pulsed with recombinant HBV envelope proteins elicit a TH2 type immune response and decrease NKT lymphocytes thus preventing the induction of viral specific immunity (2003) (0)
S1648 Type II Non Classical NKT Lymphocytes Are Crucial for Alleviation of TNBS Induced Immune Colitis: A Role for the Alteration of Membrane Lipid Rafts On Dendritic Cells (2009) (0)
Why scientists, academic institutions, and investors fail in bringing more products to the bedside: the Active Compass model for overcoming the innovation paradox (2021) (0)
WS16.6 Is primary sclerosing cholangitis (PSC) a cystic fibrosis-related disorder? Electrophysiological testing and full sequencing of the CFTR gene (2015) (0)
747 Decision Making in Clinical Hepatology Using the 13C Methacetin Breath Test: Results of a 614 Patient Clinical Trial (2009) (0)
AN ARTIFICIAL INTELLIGENCE BASED THERAPEUTIC REGIMEN IMPROVES DIURETIC RESISTANCE IN HEART FAILURE (2023) (0)
The Administration of Gliadin Downregulates the Intraepithelial Lymphocytosis Induced by a Rectal Gluten Challenge (2003) (0)
788 Treatment with an endocannabinoid antagonist improves neurological function and survival in an animal model of fulminant hepatic failure (2003) (0)
Primary biliary cirrhosis and liver transplantation. (2001) (0)
Immunoglobulin preparation enriched with anti-LPS for use in the treatment and / or prophylaxis of nonalcoholic steatohepatitis (2010) (0)
A plastic anemia—associated hepatitis successfully treated by bone marrow transplantation (1998) (0)
Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective Effects (2017) (0)
S1860 The 13C Breath Test Identifies Decreased Beta-Oxidation and Improved Glucose Tolerance and Hepatic Impairment in Patients With Non Alcoholic Steatohepatitis After an Exercise and Diet Intervention (2010) (0)
HEPATIC INJURY AND VITAMIN A INGESTION. AUTHORS' REPLY (1995) (0)
Mo1211 Oral Administration of Non-Absorbable Delayed Release 6-Mercaptopurine is Locally Active in the Gut, Exerts a Systemic Immune Effect and Alleviates Crohn's Disease With Low Rate of Side Effects: Results of Double Blind Phase II Clinical Trial (2014) (0)
[361] BETA-GLUCOSYLCERAMIDE ALTERS NKT REGULATORY LYMPHOCYTES AND DECREASES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY IN MICE (2007) (0)
The predictive value of 13C-Methacetin Breath Test (MBT) for liver transplantation (LT) and death: A seven year follow up study of 206 chronic HCV infected patients (2015) (0)
Immune modulation by antibodies and antibody receptors (2008) (0)
Correlations between components of the immune system [version 1; peer review: awaiting peer review] (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Yaron Ilan?

Yaron Ilan is affiliated with the following schools:

California Institute of Technology
Albert Einstein College of Medicine
Tel Aviv University
Stanford University
Harvard University